March 13, 2026
1 min read

FDA scolds CDMO Simtra with warning letter over contamination fumbles

Simtra BioPharma Solutions was issued a warning letter by the FDA after an inspection uncovered a number of problems at the CDMO’s production plant in Halle, Germany.

Leave a Reply

Your email address will not be published.

Previous Story

FDA fires off another manufacturing-related CRL, this one to Hyloris

Next Story

FDA move on flavored vapes rattles public health experts

Previous Story

FDA fires off another manufacturing-related CRL, this one to Hyloris

Next Story

FDA move on flavored vapes rattles public health experts

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop